Literature DB >> 8661411

Assembly and release of SIV env proteins with full-length or truncated cytoplasmic domains.

A N Vzorov1, R W Compans.   

Abstract

We have used recombinant vaccinia viruses expressing full-length or truncated gag or env genes of SIVmac239 to investigate the requirements for assembly of SIV proteins. We observed that assembly of virus-like particles (VLPs) was found to be 3- to 5-fold higher with full-length Env than with the truncated forms, or than VLPs containing only Gag proteins, in primary monkey cells or various human cell lines. When cells expressing Env proteins in the absence of Gag were examined by immunoelectron microscopy, clusters of Env protein and membrane vesicles containing Env proteins were observed at cell surfaces. A low level of vesicles was released from cells expressing full-length Env, but about a 10-fold higher level was released in cells expressing a truncated form of Env [Env733(t)] in which the cytoplasmic domain is only 17 amino acids in length. Another truncated protein, Env718(t), with a short cytoplasmic tail of 3 aa, was also incorporated into VLPs at a 10-fold higher level than the full-length Env protein and was more efficiently released in vesicles. The mature SU and TM proteins were predominantly incorporated into VLPs with full-length Env, but both cleaved and uncleaved precursor proteins were present in VLPs with truncated Env as well as in Env and Env(t) vesicles. A more prominent layer of spikes was seen by electron microscopy in VLPs with truncated Env than in VLPs containing full-length Env. These results indicate that truncated Env proteins have the ability to self-associate on the cell surface and are assembled into a more closely packed array than full-length Env, which could explain the preferential incorporation of Env proteins with short cytoplasmic tails into virions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661411     DOI: 10.1006/viro.1996.0349

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus.

Authors:  Sang-Moo Kang; Richard W Compans
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Identification of two intracellular mechanisms leading to reduced expression of oncoretrovirus envelope glycoproteins at the cell surface.

Authors:  M P Grange; V Blot; L Delamarre; I Bouchaert; A Rocca; A Dautry-Varsat; M C Dokhélar
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Fusogenic variants of a noncytopathic paramyxovirus.

Authors:  Shaguna Seth; Ioanna Skountzou; Kim M Gernert; Richard W Compans
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

4.  Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B.

Authors:  Sang-Moo Kang; Qizhi Yao; Lizheng Guo; Richard W Compans
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Truncating the gp41 Cytoplasmic Tail of Simian Immunodeficiency Virus Decreases Sensitivity to Neutralizing Antibodies without Increasing the Envelope Content of Virions.

Authors:  Ellen White; Fan Wu; Elena Chertova; Julian Bess; James D Roser; Jeffrey D Lifson; Vanessa M Hirsch
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

6.  Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.

Authors:  Woan-Eng Chan; Hui-Hua Lin; Steve S-L Chen
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization.

Authors:  A N Vzorov; R W Compans
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity.

Authors:  S P Bour; C Aberham; C Perrin; K Strebel
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus.

Authors:  Masanori Kobayashi; Akihiro Iida; Yasuji Ueda; Mamoru Hasegawa
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Foamy virus envelope glycoprotein is sufficient for particle budding and release.

Authors:  Kit L Shaw; Dirk Lindemann; Mark J Mulligan; Paul A Goepfert
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.